Category Cardiovascular

Inotropic and Vasoactive Agents

Inotropic and vasoactive agents often play an important role in the management of hemodynamic instabilty in the intensive care setting. This chapter discusses the relevant pharmacology and clinical indications for the parenteral inotropic, vasodilator, and vasoconstrictor agents most frequently used…

Antiplatelet Therapy

Over the last 3 decades, clinical management and outcomes of patients presenting with acute coronary syndromes (ACSs) have improved dramatically. Better understanding of the role of the platelet in the pathophysiology of the ACS has been the fundamental pillar for…

Anticoagulation: Antithrombin Therapy

Antithrombotic therapies are a mainstay of contemporary cardiovascular medicine; it is essential for providers in the cardiac intensive care unit (CICU) to have a thorough understanding of these pharmacologic agents. Patients with acute coronary syndromes (ACSs) and those undergoing percutaneous…

Overdose of Cardiotoxic Drugs

Cardiac arrhythmias, myocardial depression, and vasodilation are the major cardiovascular effects observed in poisonings. A large number of therapeutic and nontherapeutic agents can cause toxicity directed toward the cardiovascular system, whether in the setting of an actual overdose or merely…

Pulmonary Hypertension

Over the past 2 decades, significant advances have been made in the understanding of the pathophysiology of pulmonary hypertension. In addition, dramatic improvements have occurred in the diagnostic and therapeutic approach of patients afflicted with this disease. The resulting development…

Acute Respiratory Failure

Respiratory failure is defined as the inability to maintain either the normal delivery of oxygen to tissues or the normal removal of carbon dioxide from the tissues. From a physiologic perspective, respiratory failure can be caused by diffuse pulmonary dysfunction…